| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 111,046 | 119,702 | 120,101 | 120,097 | | Cost of Revenue | 77,440 | 86,061 | 86,880 | 84,578 | | | Gross Profit | 33,606 | 33,641 | 33,221 | 35,519 | | | Operating Expenses | | Research Development | 4,532 | 4,428 | 5,086 | 5,329 | | Selling General and Administrative | 26,545 | 25,422 | 29,431 | 29,639 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,529 | 3,791 | (1,296) | 551 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (454) | (945) | (132) | (3,547) | | Earnings Before Interest And Taxes | 2,075 | 2,846 | (1,428) | (2,996) | | Interest Expense | 843 | 1,017 | 1,392 | 877 | | Income Before Tax | 1,232 | 1,829 | (2,820) | (3,873) | | Income Tax Expense | (503) | 488 | (513) | (1,641) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,735 | 1,341 | (2,307) | (2,232) | | | Non-recurring Events | | Discontinued Operations | (1,276) | (827) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 459 | 514 | (2,307) | (2,232) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $459 | $514 | ($2,307) | ($2,232) |
|
0.51% Nasdaq 
0.01 (0.20%) 
Income Statement
